{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T02:53:25Z","timestamp":1789872805893,"version":"4.0.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009010","name":"Novartis Pharmaceuticals UK Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.01116","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T04:32:35Z","timestamp":1573014755000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Tuberous Sclerosis Complex (TSC): Expert Recommendations for Provision of Coordinated Care"],"prefix":"10.3389","volume":"10","author":[{"given":"Nicholas M. P.","family":"Annear","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Appleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahabiyah","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupesh","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick F.","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Tossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Elmslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Finlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelagh","family":"Joss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Kerecuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Lipkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finbar J.","family":"O'Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Cadwgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert C. M.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian R.","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Chris","family":"Kingswood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Seminar tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/jmg.26.1.28","article-title":"Genetic aspects of tuberous sclerosis in the west of Scotland","volume":"26","author":"Sampson","year":"1989","journal-title":"J Med Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/S0140-6736(05)78872-3","article-title":"Prevalence of tuberous sclerosis estimated by capture-recapture analysis","volume":"351","author":"O'Callaghan","year":"1998","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1080\/13696998.2016.1199432","article-title":"The economic burden of tuberous sclerosis complex in the UK: a retrospective cohort study in the Clinical Practice Research Datalink","volume":"19","author":"Kingswood","year":"2016","journal-title":"J Med Econ."},{"key":"B7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ejpn.2015.11.011","article-title":"The clinical profile of tuberous sclerosis complex (TSC) in the United Kingdom: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD)","volume":"20","author":"Kingswood","year":"2016","journal-title":"Eur J Paediatr Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1749-6632.1991.tb37743.x","article-title":"Neuropsychiatric aspects of tuberous sclerosis","volume":"615","author":"Curatolo","year":"1991","journal-title":"Ann N Y Acad Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/ndt\/gfy063","article-title":"Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the tuberous sclerosis registry to increase disease Awareness","volume":"34","author":"Kingswood","year":"2019","journal-title":"Nephrol Dial Transplant."},{"key":"B10","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","article-title":"Causes of death in patients with tuberous sclerosis","volume":"66","author":"Shepherd","year":"1991","journal-title":"Mayo Clin Proc."},{"key":"B11","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1468-1331.2009.02567.x","article-title":"Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature","volume":"16","author":"Adriaensen","year":"2009","journal-title":"Eur J Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3389\/fneur.2019.00821","article-title":"Newly diagnosed and growing subependymal giant cell astrocytoma in adults with tuberous sclerosis complex: results from the international TOSCA study","volume":"10","author":"Jansen","year":"2019","journal-title":"Front Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ejpn.2011.03.010","article-title":"Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex","volume":"15","author":"J\u00f3\u017awiak","year":"2011","journal-title":"Eur J Paediatr Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ejpn.2009.03.003","article-title":"Early control of seizures improves long-term outcome in children with tuberous sclerosis complex","volume":"14","author":"Bombardieri","year":"2010","journal-title":"Eur J Paediatr Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","article-title":"Neurological and neuropsychiatric aspects of tuberous sclerosis complex","volume":"14","author":"Curatolo","year":"2015","journal-title":"Lancet Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"P2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet."},{"key":"B20","first-page":"245","article-title":"Influence of seizures on early development in tuberous sclerosis complex","volume-title":"Epilepsy Behav.","author":"Capal","year":"2017"},{"key":"B21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/qjmed\/hcy215","article-title":"The UK guidelines for management and surveillance of Tuberous Sclerosis Complex","volume":"112","author":"Amin","year":"2019","journal-title":"QJM An Int J Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.pediatrneurol.2013.08.017","article-title":"Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the international tuberous sclerosis complex consensus conference 2012","volume":"49","author":"Roth","year":"2013","journal-title":"Pediatr Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.ejpn.2012.05.004","article-title":"Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations","volume":"16","author":"Curatolo","year":"2012","journal-title":"Eur J Paediatr Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1183\/09031936.00076209","article-title":"European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis","volume":"35","author":"Johnson","year":"2010","journal-title":"Eur Respir J."},{"key":"B25","unstructured":"UK Guidelines for Managing Tuberous Sclerosis Complex: A Summary for Clinicians in the NHS2019"},{"key":"B26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2014.10.004","article-title":"Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND checklist","volume":"52","author":"De Vries","year":"2015","journal-title":"Pediatr Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1001\/jamadermatol.2018.0464","article-title":"Efficacy and safety of topical rapamycin in patients with facial angiofibromas secondary to tuberous sclerosis complex the TREATMENT randomized clinical trial","volume":"154","author":"Koenig","year":"2018","journal-title":"JAMA Dermatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pediatrneurol.2016.04.003","article-title":"Topical use of mammalian target of rapamycin (mTOR) inhibitors in tuberous sclerosis complex\u2014a comprehensive review of the literature","volume":"61","author":"J\u00f3\u017awiak","year":"2016","journal-title":"Pediatric Neurol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1093\/ndt\/gfv209","article-title":"How to routinely collect data on patient-reported outcome and experience measures in renal registries in Europe: an expert consensus meeting","volume":"30","author":"Breckenridge","year":"2015","journal-title":"Nephrol Dial Transplant."},{"key":"B30","doi-asserted-by":"publisher","first-page":"f167","DOI":"10.1136\/bmj.f167","article-title":"Patient reported outcome measures could help transform healthcare","volume":"346","author":"Black","year":"2013","journal-title":"BMJ."},{"key":"B31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pediatrneurol.2017.09.012","article-title":"Liver angiomyolipomas in tuberous sclerosis complex\u2014their incidence and course","volume":"78","author":"J\u00f3\u017awiak","year":"2018","journal-title":"Pediatr Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.pediatrneurol.2017.04.009","article-title":"The utility of surveillance electroencephalography to guide early antiepileptic drug therapy in infants with tuberous sclerosis complex","volume":"72","author":"Whitney","year":"2017","journal-title":"Pediatr Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pediatrneurol.2015.09.013","article-title":"Clinical electroencephalographic biomarker for impending epilepsy in asymptomatic tuberous sclerosis complex infants","volume":"54","author":"Wu","year":"2016","journal-title":"Pediatr Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3389\/fneur.2019.00705","article-title":"Clinical characteristics of subependymal giant cell astrocytoma in tuberous sclerosis complex","volume":"10","author":"Jansen","year":"2019","journal-title":"Front Neurol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01116\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T04:32:37Z","timestamp":1573014757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01116\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,6]]},"references-count":34,"alternative-id":["10.3389\/fneur.2019.01116"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.01116","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,6]]},"article-number":"1116"}}